It has been shown previously that cytotoxic chemotherapy, including gemcitabine in Panc1 cells, can induce stem cell fractions, as measured by side population fraction or by cell surface marker CD133 positive cell populations in pancreas cancer [32, 33]. The gene discussed is PROM1; the disease is pancreatic neoplasm.